Functional Polymorphisms in hOGG1 Gene and Neuroblastoma Risk in Chinese Children
Yizhen Wang, Zhenjian Zhuo, Yuan Fang, Lin Li, Jiao Zhang, Jing He, Xuemei Wu · Journal of Cancer · 2018
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2018
Abstract
Neuroblastoma is a lethal tumor of the sympathetic nervous system.8-Hydroxydeoxyguanine (8-OH-dG) formation is a common seen type of oxidative DNA damage, which could be repaired by human oxoguanine glycosylase 1 (hOGG1).To explore the contributing role of hOGG1 gene single nucleotide polymorphisms (SNPs) in neuroblastoma risk, we performed a case-control study by genotyping three SNPs (rs1052133 G>C, rs159153 T>C, rs293795 A>G) in hOGG1 gene.A total of 512 neuroblastoma cases and 1076 cancer-free controls were enrolled from three medical centers in China.The hOGG1 gene polymorphisms were determined using TaqMan real-time PCR.The results showed that only the rs1052133 G>C polymorphism was associated with neuroblastoma risk [GC vs.
GG: adjusted odds ratio (OR)=0.64,95% confidence interval (CI)=0.51-0.81,P=0.0002; dominant model: adjusted OR=0.71, 95% CI=0.57-0.88,P=0.002].Moreover, subjects carrying 1, 2, or 1-3 protective genotypes have less opportunity to develop neuroblastoma, in comparison to those without protective genotypes.Stratified analysis revealed that rs1052133 GC/CC carriers were less likely to develop neuroblastoma in subgroups of age >18 months, males, tumor that develops from retroperitoneal, mediastinum and clinical stage I+II+4s.Our results indicate that hOGG1 rs1052133 G>C polymorphism is associated with decreased risk of neuroblastoma.However, the exact biological mechanism awaits further research.
Open the resolved locator · 10.7150/jca.27983
Metadata licence: OpenAlex metadata (CC0)